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yyyyyyDepartment of Anesthesiology, Tufts University School of Medicine, Boston, Massachusetts.Objective. With the increasing societal awareness of the prevalence and impact of acute pain, there
is a need to develop an acute pain classification system that both reflects contemporary mechanistic
insights and helps guide future research and treatment. Existing classifications of acute pain condi-
tions are limiting, with a predominant focus on the sensory experience (eg, pain intensity) and phar-
macologic consumption. Consequently, there is a need to more broadly characterize and classify the
multidimensional experience of acute pain.
Setting. Consensus report following expert panel involving the Analgesic, Anesthetic, and Addic-
tion Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION), American Pain
Society (APS), and American Academy of Pain Medicine (AAPM).
Methods. As a complement to a taxonomy recently developed for chronic pain, the ACTTION public-
private partnership with the US Food and Drug Administration, the APS, and the AAPM convened a
consensus meeting of experts to develop an acute pain taxonomy using prevailing evidence. Key issues
pertaining to the distinct nature of acute pain are presented followed by the agreed-upon taxonomy.
The ACTTION-APS-AAPMAcute Pain Taxonomywill include the following dimensions: 1) core criteria, 2)
common features, 3) modulating factors, 4) impact/functional consequences, and 5) putative patho-
physiologic pain mechanisms. Future efforts will consist of working groups utilizing this taxonomy
to develop diagnostic criteria for a comprehensive set of acute pain conditions.
Perspective. The ACTTION-APS-AAPM Acute Pain Taxonomy (AAAPT) is a multidimensional acute
pain classification system designed to classify acute pain along the following dimensions: 1) core
criteria, 2) common features, 3) modulating factors, 4) impact/functional consequences, and 5) puta-
tive pathophysiologic pain mechanisms.
Conclusions. Significant numbers of patients still suffer from significant acute pain, despite the
advent ofmodernmultimodal analgesic strategies.Mismanaged acute pain has a broad societal impact
as significant numbers of patients may progress to suffer from chronic pain. An acute pain taxonomy
provides a much-needed standardization of clinical diagnostic criteria, which benefits clinical care,
research, education, and public policy. For the purposes of the present taxonomy, acute pain is consid-
ered to last up to sevendays,withprolongation to30daysbeingcommon. The currentunderstandingof
acutepainmechanismspoorly differentiates betweenacute and chronic painand is often insufficient to
distinguish amongmany types of acute pain conditions. Given the usefulness of the AAPTmultidimen-
sional framework, theAAAPTundertooka similar approach toorganizingvariousacutepain conditions.
ª 2017 The Authors. Published by Elsevier Inc. on behalf of the American Pain Society. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Key words: Acute pain, taxonomy, ACTTION, biopsychosocial, AAAPT, AAPT.Introduction
n contrast with the pathophysiologic state of chronic
pain, acute pain is one of life’s inevitable core experi-
ences and has been evolutionarily preserved to serve
a critical role in protecting the host against a myriad of
threats. Despite this critical role in protecting the host,
acute pain can be associated with suffering and a reduc-
tion in physical function and productivity—thereby
causing a significant burden on the person, their family,
and society as a whole. It is now appreciated that acute
pain represents a major public health problem.
One of the challenges to both researchers and clini-
cians is in understanding the distinction between acuteand chronic pain. This distinction is important as a better
understanding of acute pain may help us to devise
therapies to prevent the development of chronic pain.
Furthermore, better classification of these pain condi-
tions will help promote more safe, effective, and tar-
geted treatments for individuals suffering from acute
pain. Unfortunately, we currently lack precision when
discussing the measurement, treatment, research, or
even public policy related to acute pain. We therefore
need an organized taxonomy of acute pain that estab-
lishes a set of common concepts, diagnostic criteria, fea-
tures, and mechanisms that defines and categorizes the
multidimensional aspects of acute pain. This
Kent et al The Journal of Pain 481classification will then promote future research into
mechanisms, prevention, and treatments for acute pain.
In 2012, an effort to enhance the precision of dialogue
about chronic pain was initiated by the Analgesic,
Anesthetic, and Addiction Clinical Trial Translations, In-
novations, Opportunities, and Networks (ACTTION) and
the American Pain Society (APS). This initiative subse-
quently developed the ACTTION-APS Pain Taxonomy
(AAPT) with the objective of creating an ‘‘evidence-
based chronic pain taxonomy based on a consistently
applied multidimensional framework’’.1 Taxonomy in
this sense refers to an organization of concepts arranged
using hierarchal relationships. The AAPT sought to
develop a hierarchical arrangement of characteristics of
chronic pain conditions to address the research, clinical,
and regulatory limitations of the International Associa-
tion for the Study of Pain (IASP) taxonomy of pain.
AAPT performed this by providing a ‘‘standardized,
systematic, and evidence-based approach to pain classifi-
cation that incorporates information regarding bio-
psychosocial mechanisms and that can be applied to all
common chronic pain conditions’’.2
AAPT developed an approach that included five
dimensions that incorporated emerging evidence while
retaining some conceptual features of existing chronic
pain classifications (Table 1). Further, AAPT proposed
specific categories of chronic pain conditions (ie, periph-
eral and central nervous system; musculoskeletal; orofa-
cial and cranial; visceral, pelvic, and urogenital pain; and
disease-associated pains not otherwise specified) that
would each be characterized along the five AAPT dimen-
sions by separate working groups.
In 2014, discussions began among APS, ACTTION, and
the AAPM about the value of developing a taxonomy
of acute pain. Such discussions were spurred by a resur-
gent interest in acute pain, including increased recogni-
tion of the societal burden of the transition from acute
to chronic pain, and recognition by a coauthor (DBC) of
the unique opportunity for these three organizations
to collaborate on such a taxonomy. While a priorTable 1. The ACTTION-APS Chronic Pain Taxonomy
DIMENSION
1. Core diagnostic criteria Symptoms, signs, and diagnostic test fin
differential diagnosis considerations.
2. Common features Additional information regarding the d
qualities, descriptors), nonpain featu
span considerations, including those
important in describing the disorder
3. Common medical and
psychiatric comorbidities
Medical and psychiatric disorders that
depression is comorbid with many c
conditions, that is, those chronic pai
4. Neurobiological, psychosocial,
and functional consequences
Neurobiological, psychosocial, and func
disorders and pain-related interferen
5. Putative neurobiological and
psychosocial mechanisms, risk
factors, and protective factors
Putative neurobiological and psychoso
the chronic pain condition, including
decreased descending inhibition, an
This table was reusedwith permission fromDworkin et al Multidimensional diagnostic
Taxonomy (AAPT). J Pain 2016;17(9 suppl):T1–T9.working definition of acute pain was formulated by
the AAPM Acute Pain Medicine Special Interest Group
in 2015 (Table 2), it was apparent that work was needed
to further characterize the complex nature of acute pain.
A preliminary step in conducting this work was a state-
of-the-science expert report that summarized existing
literature to inform practice education, research, and
health policy.3 The report included an important obser-
vation that the organization and integration of acute
pain science has been hampered by the lack of a taxo-
nomic structure necessary to promote widespread utili-
zation and acceptance.3 Given the AAPT’s previous
success in defining a taxonomy of chronic pain, a similar
methodology was proposed for the creation of a taxon-
omy of acute pain: the ACTTION-APS-AAPM Pain Taxon-
omy (AAAPT) for Acute Pain. The principal objective of
the first AAAPT meeting was to review the AAPT taxon-
omy for chronic pain and determine its appropriateness,
applicability, and adaptability if extended to acute pain.Importance of an Acute Pain Ontology/
Taxonomy
Prevalence of Acute Pain
Despite advances in multimodal analgesia, acute pain
remains a pervasive source of suffering. Work by Apfel-
baum et al in 2003 demonstrated that 80% of patients
suffered acute pain after surgery, and that 86% of these
patients reported moderate, severe, or extreme pain.4
Moreover, the majority of these patients experienced
worse pain following discharge from the hospital. More
recent work by Buvanendran in 2015 demonstrated that
66% of patients reported moderate, severe, or extreme
pain after surgery and 59% of patients reported
moderate, severe, or extreme pain during the first two
weeks following hospital discharge.5 Within emergency
departments, acute pain accounts for up to 78% of visits,
with a reportedmedianpain intensity of 8out of 10onan
11-point numeric rating scale (NRS).6-9 Finally, primary(AAPT) Multidimensional Framework
DESCRIPTION
dings required for the diagnosis of the chronic pain condition. Includes
61
isorder, including common pain characteristics (eg, location, temporal
res (numbness, fatigue), the epidemiology of the condition, and life
specific to pediatric and geriatric populations. These features are
but are not components of the core diagnostic criteria.61,62
commonly occur with the chronic pain condition. For example, major
hronic pain conditions. Also includes chronic overlapping pain
n conditions that are comorbid with each other.63
tional consequences of chronic pain. Examples include sleep andmood
ce with daily activities.64,65
cial mechanisms contributing to the development and maintenance of
risk and protective factors. Examples include central sensitization,
d somatosensory amplification.66
criteria for chronic pain: Introduction to the ACTTION–American Pain Society Pain
Table 2. AAPM Acute Pain SIG Working
Definition of Acute Pain
AAPM APMSIG WORKING DEFINITION: ACUTE PAIN
Acute pain is the physiologic response to and experience of noxious
stimuli that can become pathologic, is normally sudden in onset, time
limited, and motivates behaviors to avoid potential or actual tissue
injury.
482 The Journal of Pain AAAPT Acute Pain Taxonomycare physicians commonly encounter challenging acute
pain scenarios (eg, subacute postsurgical pain, acute
exacerbations of chronic back pain, acute pharyngitis).
In a prospective survey of general practitioners
providing acute pain management of ambulatory
postsurgical patients, Robaux et al demonstrated a
significant need for education and guidelines
addressing the diagnosis, optimal treatment, and
expected time course for acute pain conditions
presenting to the primary care setting.10Societal and Clinical Impact
The Institutes of Medicine’s (IOM’s) report Relieving
Pain in America: A Blueprint for Transforming Preven-
tion, Care, Education, and Research drew attention to
pain as a major health problem and placed it on the na-
tional agenda.11 This report called for work to promote
tangible objectives to advance pain treatment, educa-
tion, and research and acknowledged that not all acute
pain is being effectivelymanaged. Such efforts are neces-
sary because those with acute pain are currently not
offered comprehensive, integrated, evidence-based
assessment and treatments.
Acute pain has broader societal impact beyond the
initial suffering imparted by the originating insult. Inade-
quately managed acute pain can lead to patient dissatis-
faction, pathophysiologic sequelae, and maladaptive
behaviors.12 With musculoskeletal conditions alone, one
in four patients progresses from acute to chronic pain,
contributing to serious long-term pain and pain-related
physical disability.13 TheUSDepartment ofHealth andHu-
man Services National Pain Strategy and the Centers for
Disease Control and Prevention (CDC) guidelines on
opioid prescriptions for chronic noncancer pain, both
recently released, emphasize that chronic pain begins
with acute pain.14,15 However, the transition from acute
to chronic pain remains difficult to predict and little is
known about how to prevent its development.16
Conversely, unintended consequences of the treat-
ment of acute pain can directly threaten patient safety.
For example, there exists a wealth of data on the cardio-
vascular, renal, and gastrointestinal adverse events asso-
ciated with nonsteroidal anti-inflammatory drugs
(NSAIDS), and the risk of hepatic toxicity from over-the-
counter analgesics containing acetaminophen remain a
substantial public health problem.17-20 Public policy
debates on acute pain in the United States have
recently centered on opioid analgesics and their effects
both on near-term patient safety (eg, respiratory depres-
sion, cognitive dysfunction) and longer-term issues of
opioid use disorders. It is well known that patients whodevelop opioid use disorders often have their first expo-
sure to opioids during an acute pain episode.21,22 With
increasing numbers of surgeries and the push to better
control pain, there are concerning trends about
increases in both number and dosage of opioid
prescriptions following surgery and their contribution
to the US opioid epidemic.23 Researchers have recently
identified certain surgeries and patient vulnerabilities
that are associated with increased likelihood of being
on persistent opioids after surgery.24-27 However, much
research is needed to determine if preventive strategies
can reduce the development of opioid use disorders.
An acute pain taxonomy would be an important part
of that effort.
Do Any Acute Pain Taxonomies Exist?
The literature on acute pain assessment and treatment
largely focuses on acute pain intensity (eg, as assessed by
numerical rating scales, verbal rating scales, visual
analog scales, various facial scales, or observational
pain scales), reflecting a one-dimensional approach to
acute pain.28 Such approaches are in keeping with the
recommendations of multiple organizations in the
1990s advocating for clinically feasible, standardized ap-
proaches to pain assessment, further promulgated by
core measures utilized in single-dose analgesic trials.29
Recent studies have expanded such assessments, classi-
fying the acute ‘‘pain experience’’ through a variety of
approaches such as multidimensional pain-related pa-
tient-reported outcomes and trajectories.30 However,
no comprehensive frameworks exist that incorporate
mechanistic information in conjunctionwith pain experi-
ence, functional consequences, and psychologic/social
impact (ie, biopsychosocial experience) indexed to a
standardized array of acute pain conditions. Further,
while numerous sources (eg, textbooks, conference pro-
ceedings) have provided groupings of acute pain condi-
tions (ie, postsurgical pain, ischemic pain,
musculoskeletal pain), such groupings are not unified
within a taxonomy.
Impact on Research and Education
Initiatives
Not only would the creation of an acute pain taxon-
omy provide a much-needed standardization of clinical
diagnostic criteria, it also would benefit research and ed-
ucation. Numerous documents describe the optimization
of acute pain trial designs and call attention to gaps in
both the assessment and treatment of acute pain.29,31
For example, Gordon et al described a need for future
randomized controlled trials (RCTs) and observational
studies to include patients with defined phenotypes.31
At present, the majority of acute pain studies lack the
foundation of a comprehensive acute pain taxonomy
to codify inclusion and exclusion criteria and generally
do not capture the biopsychosocial outcomes (eg, pain
behavior, pain interference, physical function, sleep
disturbance, self-efficacy, social satisfaction, etc.) related
to acute pain.32 For example, a recentmeta-analysis of 15
RCTs addressing acute postmastectomy pain shows a
Kent et al The Journal of Pain 483predominant focus on pain intensity with little mention
of functional or biopsychosocial measures.33 However, a
growing number of investigations are utilizing multidi-
mensional measures to predict postoperative outcomes
and embrace such measures to determine analgesic effi-
cacy.34-37 Thus, beyond establishing a framework for
inclusion and exclusion criteria, an evidence-based acute
pain taxonomy offers the potential to illuminate the
complex biopsychosocial experience of acute pain and
encourage research to move beyond unidimensional
measures of pain intensity.
Importantly, a multidimensional approach to an acute
pain taxonomy would also provide an essential founda-
tion for training acute pain medicine physicians. In
2014, theAccreditation Council for GraduateMedical Ed-
ucation (ACGME) Board of Directors voted to accept
Regional Anesthesia and Acute Pain Medicine as an ac-
credited fellowship, a move that was later approved in
October 2016. Since that time, significant effort has led
to the creation of a set of competencies embracing the
comprehensive practice of acute pain medicine. An
evidence-based acute pain taxonomy will advance the
structure and content of this curriculum. Moreover, this
structure will support ongoing efforts to bolster pain ed-
ucation across medical specialties and ancillary services.Acute Pain Taxonomy Considerations:
Differentiating Acute from Chronic?
The AAAPT Steering Committee convened a meeting
of experts in April of 2016 with the goal of addressing
the need for a comprehensive acute pain taxonomy.
This two-day conference began with discussions on 1)
the need for formal taxonomies for pain and 2) whether
initial efforts in developing a taxonomy for chronic pain
by the AAPT could serve as a basis for developing an
acute pain taxonomy. Presentations on the historical
contexts of acute pain through both ancient andmodern
history segued into a review of known biological mecha-
nisms of acute pain (Table 3). Discussions then turned to
principles of taxonomic organization and the validityTable 3. Presentation Topics During AAAPT
Taxonomy Development Meeting
PRESENTED TOPICS
AAPT chronic pain effort (RF/RD)
Distinctions among acute, subacute, and chronic pain (DC)
Pathophysiologic mechanisms and acute pain conditions (TB)
Taxonomy of acute pain conditions (PT)
Acute surgical/procedural pain (CW)
Acute trauma pain (CB)
Acute musculoskeletal pain (SS)
Acute visceral pain (MK)
Cancer/immune mediated acute pain (KT)
Acute neuropathic pain (SR)
Acute orofacial pain (PD)
Acute pain in pediatric, geriatric, and special populations (SW)
Approached to providing an evidence base for acute pain diagnostic
criteria (SB)and reliability of diagnostic criteria as ameans of inform-
ing further development. Following discussions focused
on specific types of acute pain including postoperative
pain, acute pain related to trauma and burn, visceral
pain, acute cancer pain, acute neuropathic pain, acute
musculoskeletal pain, acute orofacial pain, and acute
pain in special populations such as pediatrics. These dis-
cussions culminated in a group discussion on developing
a multidimensional structure for acute pain taxonomy
based on the AAPT chronic pain initiative.Time-Based Criteria
In the AAAPT discussions, differentiation of acute pain
from chronic pain quickly emerged as a principal topic,
with an emphasis on timing as a key differentiator. His-
torically, the Food and Drug Administration has sug-
gested that pain occurring within 30 days of an insult
or injury is considered acute pain and that after 90 days
postinjury/-insult such pain is referred to as chronic
pain.32,38 Recent CDC guidelines pertaining to opioid
prescriptions posit a 72-hour period for acute pain treat-
ment of nontraumatic and nonsurgical origins.14 Other
experts have variously characterized durations of acute
pain ranging from seven to 14 days, with numerous ex-
amples throughout the perioperative, emergency
department, and primary care settings. The heterogene-
ity of definitions of acute pain with respect to delinea-
tions of time intervals, as well as clinical contexts and
excluded patient populations, highlights the gaps and
opportunities raised with most of the a priori time
thresholds.
In the search for a definitive cut-point between acute
and chronic pain, it is important to consider the perspec-
tive that acute and chronic pain are not entirely ‘‘sepa-
rate’’ entities, but rather different aspects along a
continuum of pain.39 This continuum may extend
beyond established characteristics of intensity and
timing; for instance, contexts such as initial pain intensity
ratings may influence the segue between acute and
chronic.40 Given the perspective of a continuum from
acute to chronic pain, a clear separation of acute from
chronic pain may be impossible, and a focus on ‘‘at
what time’’ acute pain becomes chronic may be
misguided or misleading and unnecessary. At present,
the vague and ill-defined term ‘‘subacute’’ pain has
been used to define this time period where acute pain
may or may not become chronic pain. Unique attributes
of pain during this period, however, have been
described. For example, in a study of 96 patients under-
going total knee arthroplasty, more patients described
neuropathic pain symptoms at six weeks postoperatively
when compared with the immediate postoperative
setting or at later time points greater than six months.41
At this time, the term ‘‘subacute’’ is used only descrip-
tively until this period can be more precisely character-
ized mechanistically and phenomenologically.
Our evolutionary approach thus follows that of the
AAPT effort on chronic pain; we simply do not have suf-
ficient mechanistic data at this time to render a ‘‘revolu-
tionary’’ consideration of the acute to chronic transition.
484 The Journal of Pain AAAPT Acute Pain TaxonomyGiven numerous examples of prolonged and/or repeti-
tive nociception/pain events that do not progress into
chronic pain, future iterations of the AAAPT taxonomy
may be able to better focus on the ‘‘why’’ and ‘‘how’’
for the transition between acute and chronic pain rather
than solely its temporal parameters.
Despite concerns regarding a formal cutoff point for
acute pain, AAAPT adopted the following time-based
definition of acute pain for pragmatic and heuristic pur-
poses at this time:
Acute pain is considered to last up to seven days, with
the following qualifications:
1. Its duration reflects the mechanism and severity of
the underlying inciting event.
2. Prolongations from seven to 30 days are common.
3. Prolongations beyond the duration of acute pain
but not extending past 90 days postonset/-injury
are common. This refers to the ill-defined but
important period of ‘‘subacute’’ pain that warrants
further specification and consideration in future
taxonomic, research, and regulatory efforts.
4. Our understanding of pain mechanisms is currently
insufficient to link these durations to specific phys-
iologic mechanisms.Unique Attributes of Acute Pain
Apart from the temporal differentiation separating
acute and chronic pain, there are other characteristics
that differentiate the two conditions. One of the fore-
most differences between acute and chronic pain re-
mains the ambiguity of its contextual meaning. Acute
pain has often been considered a protective mechanism
against further injury that may facilitate recovery from
injury. Those aspects of acute pain that are normative,
protective, and helpful deserve special attention as
they contrast starkly with chronic pain, which is invari-
ably considered pathologic with no direct benefit to
the patient. Such contrasts are not unique to acute and
chronic pain. For instance, immune function and inflam-
mation are generally considered normative, protective
responses against insults yet can generate pathologic
states that are life-threatening (eg, sepsis, autoimmune
disease).42,43 Notably, as with allergy, inflammation,
anaphylaxis, and sepsis, the transition points seem key,
yet the nature of the points of inflection remains
enigmatic.Mechanism-Based
Similar to the AAPT chronic pain experience, it was
hoped that the AAAPT could inform its dimensional
constructs by mapping onto underlying pain mecha-
nisms. As with chronic pain, it was agreed that the cur-
rent understanding of acute pain mechanisms poorly
differentiates between acute and chronic pain and is
often insufficient to distinguish among many types of
acute pain conditions. One of the foremost examples
of such a failure is the intertwined nature of the path-
ophysiologic mechanisms (eg, nociceptive, neuropathic,
inflammatory, ischemic) contributing to acute pain. As
each of these components is present in nearly all acutepain conditions, distinguishing among acute pain con-
ditions according to their nociceptive, neuropathic, or
inflammatory components is presently infeasible. A
similar issue arises in considering biochemical mediators
as current evidence suggests that acute and chronic dis-
ease states often display similar profiles of peripheral
mediators.
Another approach to differentiate between acute and
chronic pain, or among acute pain types, is to consider
whether the mechanism of sensitization is peripheral or
central. Although acute pain may initially involve prom-
inent peripheral sensitization, it may also occur during
chronic pain and therefore discourages reliance on the
criterion of peripheral sensitization as a key differentia-
tor between acute and chronic pain. On the other
hand, central sensitization seems to play a larger role
(and has been characterized more extensively) in chronic
pain conditions but yet is evident in acute pain as well.
Future research will be needed to better characterize
the relative contributions of peripheral and central sensi-
tization to the overall acute pain process—and its transi-
tion to chronic pain.
The presence and nature of tissue injury probably dif-
ferentiates best between acute and chronic pain, as well
as among different types of acute pain conditions. At the
level of tissue injury, distinct profiles of injured struc-
tures, tissue-specific mediators, receptors, and responses
may help differentiate acute pain conditions. For
instance, the high affinity receptor (trkA) for the noci-
ceptive mediator nerve growth factor (NGF) is expressed
in notably higher levels in visceral bladder afferent vs
cutaneous sensory afferents.44 Further, acute pain stem-
ming from periosteal injury has distinct mechanisms, me-
diators, and transmission compared with acute pain
stemming from cutaneous injury. While many examples
of acute tissue injury involve damage to an array of tis-
sues (post-traumatic or postsurgical models), other etiol-
ogies are more tissue specific. For example, acute
neuropathic pain may be in part initiated by infectious
and inflammatory injury, more specifically to neural
structures such as dorsal root ganglion neurons. Simi-
larly, certain types of acute pain are strongly associated
with a particular anatomic location, for example, frac-
ture or burn pain.Dimensional Considerations
Given the usefulness of the AAPT multidimensional
framework, the AAAPT undertook a similar approach
to organizing various acute pain conditions. In the
consensus approach that emerged from the AAAPT dis-
cussions, acute pain and chronic pain are considered sub-
classes of pain. Acute pain conditions are broadly
characterized according to the five dimensions that are
described below. Specific categories of prototypical
acute pain conditions would be differentiated according
to these five dimensions. Notably in this construct, each
dimension can be further organized as needed during
future iterations. A strategic decision was made to defer
discussions on acute pain assessment and treatment for a
future effort.
Table 4. AAAPT Acute Pain Dimensions
Dimension 1: Core criteria Specifies the inciting event, timing from the event, and tissue involved. Inciting events descriptions include
ICD10x diagnostic and/or procedure codes where possible.
Dimension 2: Common features Characterizes the acute pain condition through common pain variables (symptoms, signs, quality).
Emphasizes temporal trajectory, physical spatial distribution, and recovery expectations.
Dimension 3: Modulating factors Includes comorbidities (ie, opioid tolerance) as well as sociodemographic, biopsychosocial, and surgical
factors that may modulate the acute pain experience. Biopsychosocial risk factors (eg, catastrophizing) for
significant acute pain are considered here.
Dimension 4: Impact/functional
consequences
Describes the recovery trajectory including the interrelations of physical, social, psychologic, and vocational
consequences resulting from the acute pain condition.
Dimension 5: Putative mechanisms Includes the neurobiological mechanisms related to the acute pain condition. Considers all phases of the
acute pain experience and identifies risk factors for development of significant acute pain. Addresses
genetic- and mechanism-based processes to guide treatment.
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Discussion on how to categorize acute pain conditions
began with the five dimensions used for the AAPT. These
were extended to consider 10 to 12 dimensions, before
then collapsing back to a final five dimensions aligned
with, but differing from, the AAPT chronic pain dimen-
sional framework. The rationale for this approach
included recognition of the close link between acute
and chronic pain and the potential benefits of aligning
their dimensional structures for research andpractice up-
dates. The AAAPT specified that no one dimension be
considered more important than or superior to the
others. The five dimensions for the AAAPTwere finalized
as 1) core criteria, 2) common features, 3) modulating
factors, 4) impact/functional consequences, and 5) puta-
tive pathophysiologic pain mechanisms (Table 4).Dimension 1: Core Criteria
The core criteria represent the key features of a given
acute pain condition that permit it to be diagnosed and
distinguished from other acute pain conditions. Unlike
the AAPT dimension 1 for chronic pain, which empha-
sizes the clinical features of the pain condition itself,
the core criteria here put greater emphasis on the nature
of the inciting event. This is because, in many cases,
distinct acute pain conditions may not differ so much in
their characteristic signs and symptoms, but rather, in
their inciting event, a feature not always identifiable in
chronic pain. Moreover, the inciting event would often
be associated with a specific International Classification
of Disease Version 10 (ICD10x) diagnostic or procedure
code that in turn would link the acute pain taxonomy
to established diagnostic and procedural ontologies.
The international standardization of the ICD system links
this dimension to a broader array of efforts to codify
various classification systems used throughout health
care. This feature also permits the AAAPT taxonomy to
alignwith existing clinical entities. Further, this approach
enables a mechanism to remap the existing dimensional
framework to future disease classification schemas ac-
cording to the prescribed approaches normally specified
during such ICD transitions.
Another key aspect of dimension 1 is the time elapsed
from the inciting event to the observation of the patient,
which is critical for defining the condition as ‘‘acute.’’ Ifnot specified, the time from the inciting event within
this framework is presumed to follow the proposed
time-based criteria for acute pain described above.
The core criteria are intended to be the defining as-
pects of each condition. They differ from dimension 2:
common features, in that the latter is intended to be a
more comprehensive and descriptive collection of char-
acteristics of each acute pain condition that are not
necessary for a diagnosis.Dimension 2: Common Features
Attributes of this dimension include common pain-
related signs, symptoms, and qualities of each acute
pain condition. Special emphasis was placed on three
additional attributes in this category: temporal trajec-
tory, spatial and anatomical distribution, and anticipated
recovery. Current and anticipated temporal trajectories
(ie, characteristic changes in a given pain measure over
time in the acute phase) are key elements given their
impact on both treatment and the acute-to-chronic tran-
sition. Likewise, spatial and anatomical distribution is in-
tended to reflect not only radiation but also peripheral,
and potentially central, sensitization. Anticipated recov-
ery refers to the expected duration of recovery, but could
also be considered a binary response. For example, pa-
tients suffering from an uncomplicated ankle sprain
will substantially recover pre-injury function, while pa-
tients suffering from hemipelvectomy for sarcoma will
likely suffer from persistent pain and loss of functioning
stemming in part from this pain. Although it is a specific
attribute distinct from other features, anticipated recov-
ery is frequently impacted by core criteria (dimension 1),
modulating factors (dimension 3), impact/functional
consequences (dimension 4), and putative pain patho-
physiologic mechanisms (dimension 5).Dimension 3: Modulating Factors
Modulating factors include not only comorbid medi-
cal conditions, but also sociodemographic, biological,
clinical, behavioral, and affective conditions likely to
modulate the acute pain experience (eg, pain cata-
strophizing, state anxiety, opioid tolerance, evidence
of central sensitization, adverse childhood experi-
ences).35,36,45-47 These factors may include factors
pertaining to spatiotemporal summation and diffuse
Table 5. Acute Pain Categories to be Defined
Under Dimensional Structure in Future
Working Groups
ACUTE PAIN CATEGORIES
SURGICAL/PROCEDURAL NONSURGICAL
Cardiovascular surgery
Dental surgery
General surgery
Neurosurgery
Obstetric/gynecologic surgery
Ophthalmic surgery
Orthopedic surgery
Otolaryngology
Out of operating room procedures
Pediatric surgery
Plastic and reconstructive surgery
Thoracic surgery
Transplant surgery
Urology
Acute neuropathic
(eg, radiculopathy)
Acute ischemic
(eg, myocardial ischemia)
Visceral (eg, renal colic)
Trauma (including burns)
Orofacial
Musculoskeletal
Special populations
Adolescent
Cancer
Elderly
Labor
Pediatric/neonatal/fetal
Sickle Cell
Other
486 The Journal of Pain AAAPT Acute Pain Taxonomynoxious inhibitory control, which more recently has
been termed conditioned pain modulation to specify
‘‘psychosocial paradigms in which a conditioning
stimulus is used to affect a test stimulus’’.48-51
Dimension 3 strongly considers the context of the
inciting event. This context includes not just the
events surrounding the inciting event of dimension 1,
but also the social setting in which the patient lives
and works. Such environmental factors may extend to
the treatment environment and clinicians that may
influence which diagnostic and therapeutic
interventions are offered. For example, following a
significant acute pain event, availability of analgesic
modalities/techniques is highly dependent on the
environment of care (clinic, rural hospital, large
tertiary care center). Previous pain experiences may be
included here. Finally, a variety of neurobiological
mechanisms may also modulate the acute pain
experience. While far from condition specific, such
mechanisms may serve as risk factors for significant
acute pain by either impacting pain sensitivity (eg,
genetic variants of COMT, TRPA1) or influencing
treatment options such as in drug metabolism/
receptor interaction (eg, genetic variants of CYP2D6,
OPRM1).52-56
Dimension 4: Impact/Functional
Consequences
The fourth dimension describes the recovery trajectory
including the interrelations of physical, social, psycho-
logic, and vocational consequences resulting from the
acute pain condition. This dimension highlights that in
acute pain syndromes the acute pain itself may not be
the principal factor requiring attention, but rather an
important hurdle to recovery from the principal diag-
nosis/procedure. For example, patients undergoing total
hip arthroplasty reporting severe pain also report signif-
icant disturbances in social relations and mood.57 Opera-
tionally, the National Pain Strategy has taken the step of
defining ‘‘high-impact chronic pain’’ as ‘‘being associated
with substantial restriction of participation in work, so-
cial, and self-care activities for six months or more.’’
Similar definitions could also be applied to ‘‘high-impact
acute pain.’’
Dimension 5: Putative Pain
Pathophysiologic Mechanisms
When possible, this dimension characterizes pain-
relevant neurobiologic pathways prior to, during, and
after the inciting event. This dimension delineates the
step-by-step natural history of nociceptive, neuropathic,
and inflammatory processes that occur at the site of
injury, extending through cerebral processing. One
example would be activation of visceral nociceptive af-
ferents (eg, TRPV1 activation in urothelial cells) that
transmit noxious stimuli via autonomic ganglia through
a variety of spinal pathways (eg, spinohypothalamic) ul-
timately processed in cerebral locations such as the ante-
rior cingulate gyrus.58-60While we lack the knowledge to
classify acute pain conditions on a purely mechanisticbasis and many overlapping mediators exist, such
condition-specific descriptions provide a platform for
future research and clarification. Further, while the exact
processes underlying the transition from acute to chronic
pain remain nebulous, initial iterations of this taxonomy
will consider descriptions of such postulatedmechanisms
(eg, peripheral/central sensitization) for at-risk acute
pain conditions (eg, amputation, thoracotomy, poly-
trauma).Acute Pain Categories
Organization of specific prototypical acute pain condi-
tions diverged from the AAPT model in allowing two
broad categories, within which particular conditions
would be placed (Table 5). The first category specifically
considers acute pain related to surgery, including proce-
dural pain. Within this category fall acute pain condi-
tions related to different types of surgery, such that
acute pain from appendectomy could be differentiated
from acute pain from thoracotomy, knee replacement,
or cesarean delivery. For current purposes, we use the
term ‘‘procedural pain’’ to refer to acute pain that exists
during the time of a procedure itself, implying the expec-
tation of minimal to no postprocedural discomfort. Ex-
amples of this might include percutaneous insertion of
an intravenous catheter, endoscopy, cardiac catheteriza-
tion, or extracorporeal shock wave lithotripsy.
One critical rationale for this differentiation between
surgical and nonsurgical categories of acute pain per-
tains to the timing, anticipation, and possible preven-
tive aspects of scheduled tissue injury. Importantly,
this scheduling permits the opportunity to intervene
prior to the onset of and during tissue injury and to pro-
spectively plan for analgesia and functional recovery in
the time immediately following injury. From a mecha-
nistic standpoint, intervention to decrease acute pain
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in the effort to block the transition to chronic pain.
However, further specification will be necessary to
address the role of tissue injury and pain that predates
the surgery itself.
The second category comprises acute pain related to
nonsurgical etiologies. This is a large category, and thus
subcategories of nonsurgical pain include trauma
(including burn), visceral, ischemic, orofacial, acute
neuropathic, and musculoskeletal, as manifested in the
population at large or in special populations (labor,
sickle cell, pediatrics, etc.). Similar to the aforementioned
chronic pain taxonomy, this approach is admittedly
imperfect as many of the above acute pain conditions
share overlapping characteristics with surgical acute
pain (ie, traumatic laceration vs surgical incision).
Two important nonsurgical categories, visceral and
ischemic pain, illustrate this overlap. Numerous surgical
interventions contain these pain types as subcompo-
nents. For example, surgical bowel intervention often
leads to acute visceral pain. Additionally, conditions
such as spontaneous and traumatic limb or abdominal
compartment syndrome, while largely ischemic in na-
ture, are often surgically related. Commentary on such
mechanismswill certainly be required in the futurework-
ing groups addressing surgical subtypes. However, given
the significant number of discrete acute visceral (eg,
renal colic) and ischemic (eg, myocardial ischemia)conditions that are not necessarily surgical in nature,
these were considered appropriate initial components
of the nonsurgical categories. Indeed, the context, envi-
ronment, and psychosocial modulating factors may ac-
count for greater individual variability of the pain
experience than currently available mechanistic charac-
terization of such overlapping conditions.
Further development of the description and taxonomy
of all specific acute pain subcategories will be carried out
by several ongoing AAAPTworkgroups. Each acute pain
condition will be described according to the five AAAPT
dimensions, with additional characterization as needed.Conclusion
This multidimensional framework proposed by the
AAAPT provides a taxonomy of acute pain that will allow
the various acute pain conditions to be characterized in a
uniform fashion. This acute pain taxonomy is intended to
be a dynamic framework that may continually evolve
alongside ever-emerging evidence on the nature and
impact of acute pain. While separate from the AAPT tax-
onomy of chronic pain conditions, the long-term vision is
to establish sufficient understanding of pain such that a
standard, unifying model can evolve, linking the pro-
posed dimensions of both the acute and chronic pain tax-
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